Shanghai, China

Haiyang Jiang

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2015-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haiyang Jiang. Retrieved from https://idiyas.com/inventor/haiyang-jiang-lmjjsx5u

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 12.0

ph-index = 2

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Haiyang Jiang: Pioneering Carbamate and Urea Derivatives

Introduction

Haiyang Jiang, an esteemed inventor based in Shanghai, China, has made significant contributions to the field of medicinal chemistry. With a focus on developing innovative compounds that can serve as effective medicaments, Jiang holds two patents that exhibit his dedication to advancing healthcare solutions.

Latest Patents

Haiyang Jiang’s latest patents revolve around carbamate and urea derivatives. These inventions involve compounds of a specific formula, as detailed in the patent specifications. His work not only addresses the preparation of these compounds but also emphasizes their application as medicaments, promising new avenues for therapeutic intervention.

Career Highlights

As a valuable member of Novartis AG, Haiyang Jiang has played a pivotal role in the company's research and development efforts. His expertise in medicinal compounds is instrumental in the creation of novel therapeutics designed to improve patient outcomes.

Collaborations

In his professional journey, Haiyang has collaborated with industry experts, including Yves Auberson and Mark G. Bock. These collaborations have enhanced the innovative potential of his projects, fostering an environment of teamwork and shared knowledge within the pharmaceutical landscape.

Conclusion

Haiyang Jiang continues to be a driving force in innovation within the medicinal field. Through his patents and collaborations, he remains committed to developing effective and safe medications, ultimately contributing to the health and well-being of patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…